Evidence map›Paper›PMID 27168087›Full record

ReviewCurrent opinion in anaesthesiology2016

New insights in the systemic and molecular underpinnings of general anesthetic actions mediated by γ-aminobutyric acid A receptors.

Bernd Antkowiak, Uwe Rudolph

Abstract readReview
In one paragraph

Review in Current opinion in anaesthesiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Trial
  3. SAGE-217, A Novel GABAClinical pharmacokinetics · 2020
    Trial
  4. Review
  5. Article
  6. Article
  7. Role of GABAFrontiers in cellular neuroscience · 2022
    Article
  8. GABAJournal, genetic engineering & biotechnology · 2021
    Review
  9. Isoflurane Potentiation of GABAInternational journal of molecular sciences · 2020
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. GABANeuropharmacology · 2018
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Bernd AntkowiakaDepartment of Anesthesiology and Intensive Care, Experimental Anesthesiology Section bWerner Reichardt Center for Integrative Neuroscience, Eberhard-Karls-University, Tübingen, Germany cLaboratory of Genetic Neuropharmacology, McLean Hospital, Belmont dDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Uwe Rudolph
McLean Hospital · USUniversity of Tübingen · DE

Funding

A GABA Pathway to Faster Acting AntidepressantsR01MH095905 · NIMH · MCLEAN HOSPITAL · PI RUDOLPH, UWE · 2012 to 2016
$2.0M
Regional actions of general anesthetics in inhibitory hippocampal networksR01GM086448 · NIGMS · MCLEAN HOSPITAL · PI RUDOLPH, UWE · 2009 to 2012
$1.9M
NIGMS NIH HHS R01 GM086448NIMH NIH HHS R01 MH095905
6 · The paper itself

Abstract

purpose of reviewThe review highlights novel insights into the role of γ-aminobutyric acid A (GABAA) receptors in mediating clinically relevant actions of anesthetic agents. RECENT

findingsGABAA receptors in the hippocampus are located on glutamatergic pyramidal cells and GABAergic interneurons. Etomidate-induced inhibition of a synaptic correlate of learning and memory is caused by receptors on nonpyramidal neurons, likely on interneurons that incorporate α5 subunits. Selective enhancement of α2 subunit containing GABAA receptors in the spinal cord provides antihyperalgesia against inflammatory and neuropathic pain without causing sedation, motor impairment, and tolerance development. Inflammation, traumatic brain injury, and exposure to anesthetic agents modify the expression patterns of GABAA receptors in a subtype-specific manner. These modifications may persist for weeks. The neuroactive steroid alphaxalone causes fast-onset and short-duration anesthesia in humans. Cardiovascular and respiratory side-effects are less severe than with propofol. SUMMARY: Identification of the molecular and cellular substrates involved in anesthesia and insights into disease and drug-induced alterations in the expression patterns of GABAA receptors in the central nervous system are emphasizing the need for individualized anesthesia care. Introducing neuroactive steroids into clinical anesthesia is expected to reduce cardiovascular and respiratory side-effects.

Indexed as

Anesthesia, GeneralAnesthetics, GeneralBrain InjuriesGABAergic NeuronsHippocampusHumansInflammationInterneuronsLearningMemoryNeuralgiaPregnanedionesPropofolPyramidal CellsReceptors, GABA-ASpinal CordalphaxaloneAnesthetics, GeneralPregnanedionesPropofolReceptors, GABA-A

Identifiers

PMID27168087
PMCPMC4957807
OpenAlexW2356354199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.